Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Garcia-Montojo M, Rodriguez-Martin E, Ramos-Mozo P, Ortega-Madueño I, Dominguez-Mozo MI, Arias-Leal A, García-Martínez MÁ, Casanova I, Galan V, Arroyo R, Álvarez-Lafuente R, Villar LM.

    Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients.

    EUROPEAN JOURNAL OF IMMUNOLOGY . 50(5): 685-694.

    [doi:10.1002/eji.201948423]

  • Gil-Varea E, Fedetz M, Eixarch H, Spataro N, Villar LM, Urcelay E, Saiz A, Fernández Ó, Leyva L, Ramió-Torrentà L, Vandenbroeck K, Otaegui D, Castillo-Triviño T, Izquierdo G, Malhotra S, Bosch E, Navarro A, Alcina A, Montalban X, Matesanz F, Comabella M.

    A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells.

    Journal Of Clinical Medicine . 9(3): .

    [doi:10.3390/jcm9030625]

  • Martínez-García MÁ, Ojeda-Ojeda M, Rodríguez-Martín E, Insenser M, Moncayo S, Álvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF.

    TLR2 and TLR4 Surface and Gene Expression in White Blood Cells after Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones.

    Biomolecules . 10(1): .

    [doi:10.3390/biom10010111]

  • Monreal E, Gullón P, Pérez-Torre P, Escobar-Villalba A, Acebron F, Quereda Rodríguez-Navarro C, Sánchez-Ruano L, Fernández-Félix BM, Muriel A, Pérez-Elías MJ, Masjuan J, Corral Í.

    Increased HIV infection in patients with stroke in Spain. A 16-year population-based study.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . : .

    [doi:10.1016/j.eimc.2019.10.006]

  • Mariscal-Rodríguez A, Villar Guimerans LM, López-Trascasa M, Hernández González M, Moga Naranjo E, en nombre del grupo de inmunoquímica de la Sociedad Española de Inmunología.

    Laboratory guidelines for the diagnosis of patients with cryoglobulinaemic syndrome.

    REVISTA CLINICA ESPANOLA . 219(9): 505-513.

    [doi:10.1016/j.rce.2018.10.006]

  • Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L.

    Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.

    JOURNAL OF NEUROINFLAMMATION . 16(1): 220-220. Nº de citas: 2

    [doi:10.1186/s12974-019-1590-5]

  • Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Martinez-Castrillo JC, Walter U.

    Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.

    PARKINSONISM & RELATED DISORDERS . 68: 40-45. Nº de citas: 2

    [doi:10.1016/j.parkreldis.2019.09.032]

  • Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE.

    Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

    Frontiers in immunology . 10: 2403-2403. Nº de citas: 1

    [doi:10.3389/fimmu.2019.02403]

  • Fissolo N, Cervera-Carles L, Villar Guimerans LM, Lleó A, Clarimón J, Drulovic J, Dujmovic I, Voortman M, Khalil M, Gil E, Navarro L, Álvarez-Cermeño JC, Montalban X, Comabella M.

    Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England) . 25(11): 1535-1538. Nº de citas: 1

    [doi:10.1177/1352458518786055]

  • Fraussen J, Marquez S, Takata K, Beckers L, Montes Diaz G, Zografou C, Van Wijmeersch B, Villar LM, O'Connor KC, Kleinstein SH, Somers V.

    Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD - CD27 - Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.

    JOURNAL OF IMMUNOLOGY . 203(6): 1650-1664. Nº de citas: 1

    [doi:10.4049/jimmunol.1801236]

  • Cuello JP, Martínez Ginés ML, Kuhle J, García Domínguez JM, Lozano Ros A, Romero Delgado F, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, García-Tizon Larroca S, de-León Ruiz J, Michalak Z, Barro C, Álvarez Lafuente R, Medina Heras S, Fernández Velasco JI, Tejeda-Velarde A, Domínguez-Mozo MI, Muriel A, de Andrés C, Villar LM.

    Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study.

    EUROPEAN JOURNAL OF NEUROLOGY . 26(9): 1200-1204.

    [doi:10.1111/ene.13965]

  • Peroni S, Sorosina M, Malhotra S, Clarelli F, Osiceanu AM, Ferrè L, Roostaei T, Rio J, Midaglia L, Villar LM, Álvarez-Cermeño JC, Guaschino C, Radaelli M, Citterio L, Lechner-Scott J, Spataro N, Navarro A, Martinelli V, Montalban X, Weiner HL, de Jager P, Comi G, Esposito F, Comabella M, Martinelli-Boneschi F.

    A pharmacogenetic study implicates NINJ2 in the response to Interferon- in multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England) . : 1352458519851428.

    [doi:10.1177/1352458519851428]

  • Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C.

    Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

    Frontiers in immunology . 10: 1374-1374. Nº de citas: 3

    [doi:10.3389/fimmu.2019.01374]

  • van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C.

    gMS-Classifier1 does not predict disability progression in multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England) . 25(7): 1010-1011.

    [doi:10.1177/1352458518798048]

  • Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).

    REVISTA DE NEUROLOGIA . 68(11): 468-479.

    [doi:10.33588/rn.6811.2019121]

  • Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

    Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

    Multiple sclerosis (Houndmills, Basingstoke, England) . : 1352458519845844. Nº de citas: 2

    [doi:10.1177/1352458519845844]

  • Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B.

    Perception of stigma in patients with primary progressive multiple sclerosis.

    Multiple Sclerosis Journal - Experimental, Translational And Clinical . 5(2): 2055217319852717.

    [doi:10.1177/2055217319852717]

  • Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

    Factors associated with dimethyl fumarate-induced lymphopenia.

    JOURNAL OF THE NEUROLOGICAL SCIENCES . 398: 4-8. Nº de citas: 2

    [doi:10.1016/j.jns.2019.01.007]